Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Perhaps the worst timing? One day before SAVA goes vertical, he passes. If he ever says to shun AVXL, LOAD THE TRUCK

Cassava Sciences’ Stock Remains an Enigma
Will Ashworth
Mon, November 1, 2021, 6:00 AM
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022.

I even suggested it might retest $100—a level it hit throughout the summer—by the end of 2021. I was convinced it would go on a roll.

“As I write this, it’s trading above $60 and looks ready to go on a big run in October like it did in May. This stock is so unpredictable; it would not surprise me in the slightest if it were to retest $100 before the end of the year,” I said on Oct. 4.

Like clockwork, it has lost 26% of its value in October with only a couple of trading days left in the month.

What happened to SAVA stock? It went right off the tracks.

While it remains an enigma, I’m sure there are speculative investors still considering buying SAVA. I wouldn’t, but that doesn’t mean you shouldn’t.